Parathyroid Scintigraphy - European Association of Nuclear Medicine
Parathyroid Scintigraphy - European Association of Nuclear Medicine
Parathyroid Scintigraphy - European Association of Nuclear Medicine
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Patient preparation<br />
Audrey Taylor and Nish Fernando<br />
Patient identification<br />
To minimise the risk <strong>of</strong> a misadministration:<br />
•<br />
•<br />
Establish the patient’s full name and other<br />
relevant details prior to administration <strong>of</strong><br />
any drug or radiopharmaceutical.<br />
Corroborate the data with information provided<br />
on the diagnostic test referral.<br />
If the information on the referral form does<br />
not match the information obtained by the<br />
identification process, then the radiopharmaceutical/drug<br />
should not be administered to<br />
the patient. This should be explained to the<br />
patient and clarification sought as soon as<br />
possible by contacting the referral source.<br />
The patient/parent/guardian/escort should<br />
be asked for the following information, which<br />
should then be checked against the request<br />
form and ward wristband in the case <strong>of</strong> an<br />
in-patient:<br />
•<br />
•<br />
•<br />
•<br />
Full name (check any spellings as appropriate,<br />
e.g. Steven vs Stephen)<br />
Date <strong>of</strong> birth<br />
Address<br />
If there are any known allergies or previous<br />
reactions to any drug, radiopharmaceutical,<br />
iodine-based contrast media or products<br />
such as micropore or Band-Aids<br />
A minimum <strong>of</strong> TWO corroborative details<br />
should be requested and confirmed as correct.<br />
The following information should be checked<br />
with the patient/parent/guardian/escort<br />
where appropriate:<br />
•<br />
•<br />
•<br />
•<br />
Referring clinician/GP/hospital<br />
Any relevant clinical details<br />
Confirmation that the patient has complied<br />
with the dietary and drug restrictions<br />
Confirmation that the results <strong>of</strong> correlative<br />
imaging (e.g. echocardiography, angiography,<br />
etc.) are available prior to the study, and<br />
noting <strong>of</strong> any recent interventions<br />
If in doubt, do not administer the radiopharmaceutical<br />
or drug and seek clarification.<br />
Specific patient groups<br />
This is a guide only. Patients who are unable to<br />
identify themselves for any <strong>of</strong> a variety <strong>of</strong> reasons<br />
should wear a wrist identification band.<br />
•<br />
•<br />
Hearing difficulties: Use written questions<br />
and ask the patient to supply the information<br />
verbally or to write their responses down.<br />
Speech difficulties: Ask the patient to write<br />
down their name, date <strong>of</strong> birth and address<br />
and other relevant details.